In this issue of Molecular Cell, Bhamidipati et al., 2005 and Kim et al., 2005, and Szathmary et al. (2005) demonstrate that Yos9p selectively binds to aberrant glycoproteins in the endoplasmic reticulum (ER) and targets them for destruction through the ER-associated protein degradation pathway.